Lyka Labs Ltd Share Price

Q: What is the share price of Lyka Labs Ltd today?

Lyka Labs Ltd share price as on 31 Jan 2025 is ₹147.5

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: LYKALABS Small Cap ISIN: INE933A01014

As on 31 January 2025 at 14:04 IST

₹147.50

+ 2.24

(1.54%)

Sell Buy

Over 1 Month

-8.15%

Over 6 Months

18.70%

Over 1 Year

19.41%

Over 3 Years

-15.47%

Lyka Labs Ltd Summary

Close ₹ 147.50

Open ₹ 145.05

High ₹ 148.55

Low ₹ 142.33

Volume 32,721

Net Turnover (in ₹ Cr) ₹ 0.82

52Wk High ₹ 176.59

52Wk Low ₹ 97.90

52Wk High / Low

97.90

176.59

Lyka Labs Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 518.43

EPS (TTM) 1.11

Book Value (BV) 36.64

Div. Yield -

P/E (TTM) 130.32

Price/Book Value 3.95

Delivery % 47.26 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 3.88

EV to Sales 3.78

PEG Ratio -

ROA -1.41

ROE -

Debt-Equity 0.73

Net Profit Margin -2.13

Operating Profit Margin 15.18

Lyka Labs Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	112.65	96.47	196.18	87.81	64.58
Total Expenses	113.17	102.25	130.41	100.83	93.23
Profit Before Tax	-0.93	-13.17	59.25	-14.14	-61.88
Profit After Tax	-2.62	-13.15	38.44	-10.09	-62.62
Operating Profit after Depreciation	4.37	6.09	85.89	12.92	-8.59

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	58.78	69.22	95.46	107.76	115.93
Total Non Current Assets	106.07	107.32	133.42	160.93	164.29
Total Current Assets	50.65	44.20	52.20	29.08	35.88
TOTAL ASSETS	156.72	151.52	185.61	190.01	200.17
Total Shareholder's Fund	68.15	45.44	13.34	-25.80	-14.34

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	1.77	8.95	79.25	8.81	5.32
Net Cash used in Investing Activities	-9.49	7.35	-6.17	-0.16	-0.11
Net Cash used in Financing Activities	1.95	-21.64	-63.18	-11.80	3.38

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	108.04	84.04	167.07	64.47	43.34
Total Expenses	108.92	90.08	102.16	81.44	70.74
Profit Before Tax	-0.93	-13.21	60.24	-18.40	-55.15
Profit After Tax	-2.27	-13.29	39.90	-14.46	-55.39
Operating Profit after Depreciation	3.92	5.54	84.83	8.59	-8.39

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	56.72	66.65	91.62	103.55	111.45
Total Non Current Assets	136.02	136.56	161.32	187.64	190.57
Total Current Assets	49.86	42.30	47.19	25.73	30.70
TOTAL ASSETS	185.88	178.86	208.51	213.37	221.27
Total Shareholder's Fund	99.33	76.43	44.44	4.41	18.78

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	3.09	6.87	76.53	5.75	-11.45
Net Cash used in Investing Activities	-8.61	6.77	-4.33	0.13	0.13
Net Cash used in Financing Activities	2.71	-20.33	-63.35	-7.75	19.61

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	41.16	30.11	27.77	32.56	27.99
Total Expenses	36.02	26.25	25.78	25.93	23.68
Profit Before Tax	2.87	2.01	-1.67	3.05	-0.65
Profit After Tax	2.10	1.44	-2.13	1.78	-0.49
Operating Profit after Depreciation	5.17	4.42	2.28	7.17	4.56

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	41.16	30.10	26.98	31.42	26.76
Total Expenses	35.82	26.05	24.77	25.56	22.83
Profit Before Tax	3.27	2.34	-1.22	2.40	-0.45
Profit After Tax	2.47	1.75	-1.62	1.36	-0.29
Operating Profit after Depreciation	5.47	4.67	2.60	6.38	4.23

Lyka Labs Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 142.27

S2 139.28

S3 134.56

Pivot 146.99

R1 149.98

R2 154.70

R3 157.69

Moving Average

20 SMA 153.88

50 SMA 156.17

100 SMA 151.11

200 SMA 135.49

Lyka Labs Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 01 Aug 2022

In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved Please refer to our letter dated 20th May, 2022 wherein we have informed you about the date of Annual General Meeting as 05th August, 2022 and Book Closure period of 7 days from 29th July, 2022 to 05th August, 2022 ( Both days inclusive ) for the purpose of Annual General Meeting. We have rescheduled the Annual General Meeting and it will now be held on Monday, 01st August, 2022 at 12.15 p.m. by other audio - visual means (OAVM). The Book Closure period is revised for a period of 8 days from 25th July 2022 to 01st August, 2022 (Both days inclusive) for the purpose of Annual General Meeting. Kindly note the above changes on your record. (As Per BSE Announcement dated on 25.05.2022) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) 2015, we enclose herewith Summary Proceedings of the 43rd AGM of Lyka Labs Limited ('the Company') held on Monday, 1st August, 2022 at 12:15 p.m. through Video Conference (VC)/Other Audio Visual means (OAVM). (As Per BSE Announcement Dated on 02.08.2022) The Company convened its 43rd Annual General Meeting on 1st August, 2022 and the business mentioned in the Notice was transacted and passed with requisite majority. In this regard, we enclose herewith the following; 1. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2. Report of the Scrutinizer from Mr. Kaushal Doshi of M/ s Kaushal Doshi & Associates - Practicing Company Secretary dated 2nd August, 2022, pursuant to Section 108 of the Companies Act, 2013 and Rule 20 (4) (xii) of the Companies (Management and Administration), Rules 2014. This is for your information and record. Lyka Labs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 03.08.2022)

AGM Date: 02 Aug 2023

Notice of 44th Annual General Meeting Pursuant to Regulation 30 & 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; the following documents which are being sent to the Members of the Company: 1. Notice of the 44th Annual General Meeting to be held on Wednesday, 2nd August 2022; and 2. Annual Report for the Financial Year ended 31st March, 2023. (As Per BSE Announcement Dated on 10.07.2023) Book Closure from 24th July 2023 to 1st August 2023 (As per BSE Announcement Dated on 14/07/2023) Book Closure for 44th Annual General Meeting (As per BSE Announcement Dated on 17/07/2023) The 44th Annual General Meeting of the Company was held on 2nd August 2023 at 11 am through Video Conferencing / Other Audio Visual Means. Pursuant to Reg 30 of the SEBI (LODR) Regulations 2015, please find enclosed the summery of proceedings. In compliance with Reg 44 (3) of SEBI (LODR) Regulations, 2015; the Consolidated results of e-voting of the AGM in the prescribed format along with the Scrutinizer Reports. Considering the votes cast in favour of the resolutions, all the resolutions were carried (passed) with requisite majority. (As Per BSE Announcement Dated on 03/08/2023)

AGM Date: 09 Aug 2024

The Company inform the book closure for its Annual General Meeting, as detailed therein. The Company enclosed the notice of the 45th Annual General Meeting and the Annual Report for the Financial Year 2023-24. (As Per BSE Announcement Dated on: 16/07/2024) Proceedings of Annual General Meeting held on 09th August 2024 Scrutinizer Report for the Annual General Meeting of the Company held on 09.08.2024 (As Per BSE Announcement Dated on 09.08.2024)

EGM Date: 17 Feb 2023

EGM 17.02.2023 In continuation to earlier communication on 21st January 2023, Notice of Extra Ordinary General Meeting is attached herewith of the Company to be held on Friday, 17th February 2023 at 11:00 a.m. through Video Conferencing (VC)/Other Video Visual Means (OAVM). (As Per BSE Bulletin Dated on 23.01.2023) In continuation to earlier communication on 21st January 2023, Notice of Extra Ordinary General Meeting is attached herewith of the Company to be held on Friday, 17th February 2023 at 11:00 a.m. through Video Conferencing (VC)/Other Video Visual Means (OAVM). (As Per BSE Announcement Dated on 24/01/2023) In continuation to our earlier communication on 24th January 2023, we hereby confirmed that the notices of the Extra Ordinary General Meeting (the 'EOGM') to be held on 17th February 2023, were sent to the Members on their registered email ID, through 'NSDL'. Following are the major timelines, as mentioned in the notice of the EOGM: Cutoff date for e-voting 10th February 2023 e-voting start date 13th February 2023 (from at 09:00 a.m. IST) e-voting end date 16th February 2023 (upto at 05:00 p.m. IST) Date and time of the EOGM 17th February 2023 at 11:00 a.m. (As Per BSE Announcement Dated on 25.01.2023) EGM 17/02/2023 (As Per BSE Bulletin Dated on 25.01.2023) The Extra Ordinary General Meeting (the 'EOGM') of the Members of Lyka Labs Limited was held on Friday, 17th February 2023 at 11:00 a.m. through Video Conferencing (VC) in compliance with the applicable provisions under the Companies Act, 2013; SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015 and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities Exchange Board of India, in this regard. The summary of the proceedings of the EOGM is enclosed. In Compliance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; consolidated result of e-voting of the EOGM in the prescribed format along with the Scrutinizer''s report are enclosed. (As Per BSE Announcement Dated on 17/02/2023)

EGM Date: 20 Feb 2024

Notice of the meeting of equity shareholders to be held as per the order of the honble NCLT Intimation of sending of notices of the meetings of the shareholders and the creditors (As Per BSE Announcement dated on 19.01.2024) Summary of Proceedings of the NCLT Convened Meeting of the Secured Creditors of the Company. (As Per BSE Announcement dated on 20.02.2024) Voting Results of the meeting of Equity Shareholders of the Company (As per BSE Announcement Dated on 21/02/2024)

Lyka Labs Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Lyka Labs Ltd	₹144.65	₹516.26
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Lyka Labs Ltd News

Lyka Labs announces board meeting date

On 4 February 2025

03 Jan 2025, 09:46 am

Lyka Labs to declare Quarterly Result

On 4 February 2025

30 Dec 2024, 06:47 pm

Lyka Labs announces board meeting date

On 12 November 2024

23 Oct 2024, 10:45 am

Lyka Labs to hold board meeting

On 11 October 2024

04 Oct 2024, 04:39 pm

Lyka Labs to hold board meeting

On 9 August 2024

02 Aug 2024, 11:26 am

Lyka Labs Ltd Stock Analysis

Annual revenue for Lyka Labs Ltd increased by 28.56% to ₹108.04 crore in FY 2024 from ₹84.04 crore in FY 2023.
Annual Net Profit for Lyka Labs Ltd decreased by 82.92% to ₹-2.27 crore in FY 2024 from ₹-13.29 crore in FY 2023.
Promoter Shareholding in Lyka Labs Ltd remains unchanged by 0.00% in the most recent quarter, from 58.10% in September 2024 to 58.10% in December 2024.
Lyka Labs Ltd delivered a 1-year return of 19.41% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Lyka Labs Ltd share price moved up by 1.54% from its previous close of INR ₹145.26. The latest Lyka Labs Ltd share price is INR ₹147.50.
Lyka Labs Ltd share price today has been at a low of 142.33 and a high of 148.55. Over the past 52 weeks, the Lyka Labs Ltd share price has seen a low of 97.90 and a high of 176.59.